American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Division
        • AHNS Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Fellowship Curriculum for FY2024-2025
      • For Current AHNS Fellows
      • Certificate of Completion Request
    • Accredited Fellowships
      • Directory of Fellowships
      • AHNS Fellowship Match
      • Fellowship Curriculum
      • Fellowship Graduates
      • For Program Directors
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
      • Head and Neck Reconstruction- Information for Patients
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland Section
      • Salivary Gland Section Patient Education Handout: Parotidectomy
    • Cutaneous Cancer
  • Find-A-Physician
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Login
    • Password Reset
  • Donate

Published on February 2, 2024 by

A DANIEL PINHEIRO – Springfield Missouri

← Go back

A DANIEL PINHEIRO

Mercy Clinic

  • 27
  • 18
  • 26

1229 East Seminole Street
Springfield, Missouri 65804
United States
Map It

417-820-5750

mercy.net

I am proud to be part of an organization whose mission statement is to "... bring to life the healing ministry of Jesus through our compassionate care and exceptional service." Compassionate care and exceptional service are the hallmark of our comprehensive, holistic and multidisciplinary care of those touched by tumors of the thyroid , parathyroid and the head and neck.

The following trials are currently available through CRO (Cancer Research of the Ozarks):

EA3132

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing

 

NRG-HN001

ClinicalTrials.gov NCT02135042

RANDOMIZED PHASE II AND PHASE III STUDIES OF INDIVIDUALIZED TREATMENT FOR NASOPHARYNGEAL CARCINOMA BASED ON BIOMARKER EPSTEIN BARR VIRUS (EBV) DEOXYRIBONUCLEIC ACID (DNA)

 

RTOG 0920

A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER

 

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY

A091305

A PHASE 2 STUDY OF EFATUTAZONE, AN ORAL PPAR AGONIST, IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED ANAPLASTIC THYROID CANCER

WF 97115

A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer

ECOG-ACRIN EA 6134 – Randomizes between Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at progression or Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at progression.  BRAF V600 mutation is required, and patients must have Stage IV or unresectable Stage III, measurable disease.

SWOG S1320 – Randomizes between intermittent versus continuous dosing of Dabrafenib + Trametinib for BRAF V600E/K mutant, Stage IV or unresectable Stage III, melanoma. Again, patients must have measurable disease.

SWOG S1616 – Randomizes between Nivolumab + Ipilimumab or Ipilimumab alone in Stage IV or unresectable Stage III melanoma patients with measurable disease refractory to Anti-PD-1 or Anti-PD-L1 agents.

SWOG S1512 – Phase II trial of PD-1 blockade with Pembrolizumab in resectable or unresectable desmoplastic melanoma. Also requires measurable disease

SWOG S1607 – Phase II trial combining T-VEC (talimogene laherparepvec) + Pembroluzumab in patients with in Stage IV or unresectable Stage III melanoma patients with measurable disease who have progressed on Anti-PD1/L1 based therapy. Patients must have 2 cutaneous, subcutaneous or nodal lesions which are injectable.

Akin RD, Pinheiro AD (2020) Hypercalcemic crisis secondary to a superior mediastinal parathyroid adenoma: A case report. Ear, Nose & Throat J. July 15, 2020 OnlineFirst. doi.org/10.1177/0145561320942021

Rizvanovic H, Thomas J, Pinheiro AD, Kim KT (2020) Advances in diagnosis and treatment of thyroid cancer. Archive of Cancer and Oncology 1(1): 2-5, doi:10.31487/nl.ACO.2020.01.02

Rizvanovic H, Kim KT, Pinheiro AD, Thomas J (2020) Chlorotoxin conjugated with Saporin reduces viability of ML-1 thyroid cancer cells in vitro. J Biochem Mol Med 2(2): 107-112

Pinheiro AD, Kramar RW (2016) Determinants of Cost in the Treatment of T1-T3 Oropharynx Cancer. International journal of radiation oncology, biology, physics. 94(4):866; DOI10.1016/j.ijrobp.2015.12.026

Pinheiro AD (2015) Oropharynx cancer: a sexually transmitted disease? Journal of the Greene County Medical Society, 73(1):8-9.

Pinheiro AD (2002) Parotid neoplasms: the lump near the mandible? Current Surgery 59:509-517.

Pinheiro AD, Foote RL, McCaffrey TV, Kasperbauer JL, Bonner JA, Olsen KD, Cha S, Sargent D (2003)

Intraoperative radiotherapy for head and neck and skull base cancer. Head and Neck, 25:217-226.

Boahene DK, Olsen KD, Lewis JE, Pinheiro AD, Pankratz VS, Bagniewski SM (2004) Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. Arch Otolaryngol Head Neck Surg. 130(7):849-56.

Kay PA, Pinheiro AD, Lohse CM, Pankratz VS, Olsen KD, Lewis JE, Nascimento AG. (2004) Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical study of 28 cases. Int J Surg Pathol. 2004 12(1):17-24

Shashy RG, Pinheiro AD, Olsen KD (2006) Toxoplasmosis lymphadenitis presenting as a parotid mass: a report of 2 cases. Ear Nose Throat J. 2006 Oct;85(10):666-8

 

Related

© 2002–2025 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc